VoxNeuro, a company specializing in EEG-based brain performance software, has successfully completed its second financing round, raising nearly $3.4 million. The funding was led by the company’s largest shareholder and supported by strategic investor g.tec, a brain-computer interface and neurotechnology company that supplies EEG hardware to VoxNeuro.
The funds will be used to expand commercial operations and scale clinical installations across the United States to meet the increasing demand for cognitive assessments, promote brain health equity, and further enhance the software through research and development.
VoxNeuro aims to become “The Brain Company” and is committed to providing innovative solutions that give everyone’s brain a voice. The company’s brain performance software offers research-intensive cognitive assessments to healthcare providers, contributing to improved patient outcomes.
In recent months, VoxNeuro achieved significant milestones, including securing ten new client agreements and partnering with Boston University to develop validated diagnostic tools for targeted applications in Concussion and Alzheimer’s patients. The company also presented its language-agnostic medical technology at various events, including the American Academy of Neurology Annual Meeting and the Collision Tech Conference.
With this financing, VoxNeuro aims to accelerate its product development and operational model, increase its market presence, and provide enhanced cognitive health assessments using a machine-learning algorithm.
The company has an established client success team and a robust sales and marketing strategy in place to penetrate the US market and continue its mission of transforming the brain health landscape through objective cognitive health assessments.
